Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared an LinkedIn:
”Delighted to see our study on the genetic determinants of clinical variability in type 2 von Willebrand disease now out as Early View in Haematologica Journal
This work highlights how VWF genetic variation influences the clinical expression of different types 2 VWD, and the clinical variability among cases with the same genetic variant.”
Read the full article in Haematologica Journal.
Article: Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype
Authors: Omid Seidizadeh, Alessandro Ciavarella, Luciano Baronciani, Paola Colpani, Andrea Cairo, Simona Maria Siboni, Flora Peyvandi
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications